![\"Irene](\"https:\/\/www.newsbeep.com\/us\/wp-content\/uploads\/2026\/10\/Irene_Lang_Headshot.jpg\")
<\/p>\n
Irene Lang, CEO and Cofounder of HoloMD<\/p>\n
\nLang brings an uncommon combination of behavioral science, technology, and commercialization experience. She developed machine-learning-based quantitative modeling and decision-support systems for hedge fund managers, subsequently led research initiatives at Twitter, and co-founded Eliza, an AI-enabled mental-health technology company acquired by Spring Health approximately 18 months after inception.<\/p>\n
\nAt Eliza, Lang combined behavioral research, direct customer engagement, and product development to achieve product-market fit. In one adoption initiative, her approach increased therapist engagement from approximately 15% to nearly 100% of caseload. Based in the San Francisco Bay Area, she also brings relationships across Silicon Valley\u2019s technology, startup, and investment communities.<\/p>\n
\n\u201cI told our Board that if HoloMD is going to create the category of Continuous Precision Psychiatry, we needed a CEO with capabilities different from my own,\u201d said Dr. Kehr. \u201cI wanted a Silicon Valley leader who knew how to build products people love, scale adoption, and attract capital. Among the many candidates we evaluated, Irene stood apart. Her experience, judgment, and determination complement my 40-plus years in precision psychiatry. Together, we intend to bring the soul of Potomac Psychiatry – our clinical philosophy, compassion, and expertise – to millions of patients and their families through Dr. Holo.\u201d<\/p>\n
\nHoloMD enters this next phase with early operating evidence. Its Banyan Treatment Centers 180-day paid pilot enrolled 138 patients, reported 83% retention, and generated 43 human-reviewed escalations, including 19 relapse-related alerts. These findings demonstrate meaningful engagement and actionable risk detection.<\/p>\n
\nPotomac Psychiatry was named Global Precision Psychiatry Practice of the Year 2026, while HoloMD received Mental Health Tech Innovators of the Year 2026 recognition. Dr. Kehr is a ten-year Castle Connolly Top Doctor honoree.<\/p>\n
\n\u201cTechnology succeeds when it becomes indispensable to the people using it,\u201d said Lang. \u201cHoloMD has something rare: deep clinical expertise, real patient engagement, and a foundation already operating in clinical practice. My focus is turning that foundation into a product clinicians trust, patients use, and healthcare organizations can scale economically. Bruce and I share the ambition to make Continuous Precision Psychiatry the standard of care between visits.\u201d<\/p>\n
\nWith complementary clinical and Silicon Valley leadership, HoloMD is advancing its commercialization strategy and engaging investors to support its next stage of growth.<\/p>\n
\nAbout HoloMD<\/p>\n
\nHoloMD is building the Human + AI infrastructure for Continuous Precision Psychiatry\u2122. Its Dr. Holo\u2122 platform combines ongoing patient engagement, human-reviewed risk detection, provider insights, and reimbursement-enabled clinical workflows to extend care between appointments.<\/p>\n
\nwww.HoloMD.ai<\/a><\/p>\n View source version on businesswire.com: https:\/\/www.businesswire.com\/news\/home\/20261027808584\/en\/<\/a><\/p>\n<\/p>\n